COLL insider transaction filings

COLLEGIUM PHARMACEUTICAL, INC — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-10. Screen COLL transaction legs live →

FiledFormInsiderReported transactionsSource
2026-06-104SANTINI GINO — DirectorOption exercise (M): 8,700 @ $16.49 · Option exercise (M): 8,700 (derivative) @ $0EDGAR
2026-05-204Freund John Gordon — DirectorSale (S): 20 @ $34.05EDGAR
2026-05-184Glancy Donovan Michael — DirectorGrant/award (A): 17,482 @ $0EDGAR
2026-05-184Balice-Gordon Rita J. — DirectorGrant/award (A): 8,741 @ $0EDGAR
2026-05-184Paya Carlos V — DirectorGrant/award (A): 8,741 @ $0EDGAR
2026-05-184Lurker Nancy — DirectorGrant/award (A): 8,741 @ $0EDGAR
2026-05-184Freund John Gordon — DirectorGrant/award (A): 8,741 @ $0 · Option exercise (M): 8,700 @ $16.49 · Sale (S): 4,127 @ $34.54 · Option exercise (M): 8,700 (derivative) @ $0EDGAR
2026-05-184SANTINI GINO — DirectorGrant/award (A): 8,741 @ $0EDGAR
2026-05-184BOHLIN GAREN G — DirectorGrant/award (A): 8,741 @ $0EDGAR
2026-05-154Lurker Nancy — DirectorSale (S): 4,500 @ $35.97EDGAR
2026-05-134BOHLIN GAREN G — DirectorOption exercise (M): 8,700 @ $16.49 · Sale (S): 8,700 @ $37.18 · Option exercise (M): 8,700 (derivative) @ $0EDGAR
2026-04-034Dieter David — EVP & General CounselTax withholding (F): 8,840 @ $35.72EDGAR
2026-03-204Dieter David — EVP & General CounselSale (S): 13,976 @ $34.92EDGAR
2026-03-114Dieter David — EVP & General CounselSale (S): 6,224 @ $36.65EDGAR
2026-03-054Dreyer Scott — EVP & Chief Commercial OfficerSale (S): 46,417 @ $40.36 · Sale (S): 3,559 @ $40.99EDGAR
2026-02-124Dieter David — EVP & General CounselGrant/award (A): 22,194 @ $0 · Grant/award (A): 9,005 @ $0 · Tax withholding (F): 2,781 @ $46.75EDGAR
2026-02-124Tupper Colleen — EVP & Chief Financial OfficerGrant/award (A): 26,421 @ $0 · Grant/award (A): 32,734 @ $0 · Tax withholding (F): 11,861 @ $46.75 · Tax withholding (F): 26,679 @ $46.75EDGAR
2026-02-124Smith Thomas B — EVP and Chief Medical OfficerGrant/award (A): 14,268 @ $0 · Grant/award (A): 22,774 @ $0 · Tax withholding (F): 5,897 @ $46.75 · Tax withholding (F): 11,538 @ $46.75EDGAR
2026-02-124Dreyer Scott — EVP & Chief Commercial OfficerGrant/award (A): 19,023 @ $0 · Grant/award (A): 30,702 @ $0 · Tax withholding (F): 9,977 @ $46.75 · Tax withholding (F): 21,615 @ $46.75EDGAR
2026-02-124Karnani Vikram — President and CEO, DirectorGrant/award (A): 79,264 @ $0 · Grant/award (A): 32,531 @ $0 · Tax withholding (F): 11,296 @ $46.75EDGAR
2025-12-104Dreyer Scott — EVP & Chief Commercial OfficerOption exercise (M): 17,600 @ $15.90 · Sale (S): 11,125 @ $47.89 · Sale (S): 6,475 @ $48.66 · Option exercise (M): 17,600 (derivative) @ $0EDGAR
2025-12-094Balice-Gordon Rita J. — DirectorSale (S): 3,650 @ $47.03EDGAR
2025-11-144Karnani Vikram — President and CEO, DirectorTax withholding (F): 8,983 @ $47.35EDGAR
2025-11-144Fallon John A. — DirectorOption exercise (M): 15,000 @ $16.49 · Option exercise (M): 19,853 @ $9.33 · Sale (S): 34,853 @ $47.21 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 19,853 (derivative) @ $0EDGAR
2025-11-074Tupper Colleen — EVP & Chief Financial OfficerSale (S): 25,142 @ $40.38 · Sale (S): 4,858 @ $41.28EDGAR
2025-09-034Smith Thomas B — EVP and Chief Medical OfficerSale (S): 17,478 @ $38.42EDGAR
2025-08-204Dreyer Scott — EVP & Chief Commercial OfficerOption exercise (M): 16,389 @ $21.34 · Sale (S): 16,389 @ $38.21 · Option exercise (M): 16,389 (derivative) @ $0EDGAR
2025-08-194SANTINI GINO — DirectorOption exercise (M): 15,000 @ $13.45 · Sale (S): 5,405 @ $37.19 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-08-154Dreyer Scott — EVP & Chief Commercial OfficerOption exercise (M): 4,861 @ $21.34 · Sale (S): 4,861 @ $38.03 · Option exercise (M): 4,861 (derivative) @ $0EDGAR
2025-08-154Rubric Capital Management LP — 10% owner
Rosen David Efraim — 10% owner
Sale (S): 25,000 @ $37.85EDGAR
2025-08-124Freund John Gordon — DirectorSale (S): 11,659 @ $34.36EDGAR
2025-06-114Freund John Gordon — DirectorOption exercise (M): 15,000 @ $13.45 · Sale (S): 6,601 @ $30.62 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-05-194Fallon John A. — DirectorGrant/award (A): 9,791 @ $0EDGAR
2025-05-194Lurker Nancy — DirectorGrant/award (A): 9,791 @ $0EDGAR
2025-05-194BOHLIN GAREN G — DirectorGrant/award (A): 9,791 @ $0EDGAR
2025-05-194Balice-Gordon Rita J. — DirectorGrant/award (A): 9,791 @ $0EDGAR
2025-05-194Freund John Gordon — DirectorGrant/award (A): 9,791 @ $0EDGAR
2025-05-194SANTINI GINO — DirectorGrant/award (A): 9,791 @ $0EDGAR
2025-05-194Paya Carlos V — DirectorGrant/award (A): 19,582 @ $0EDGAR
2025-03-244Tupper Colleen — EVP & Chief Financial OfficerSale (S): 1,206 @ $30.00 · Sale (S): 6,396 @ $30.03EDGAR
2025-03-244Dreyer Scott — EVP & Chief Commercial OfficerSale (S): 1,927 @ $30.00 · Sale (S): 18,881 @ $30.03EDGAR
2025-03-194Dieter David — EVP & General CounselGrant/award (A): 68,449 @ $0EDGAR
2025-03-184Tupper Colleen — EVP & Chief Financial OfficerSale (S): 977 @ $30.00EDGAR
2025-03-184Dreyer Scott — EVP & Chief Commercial OfficerSale (S): 2,255 @ $30.00EDGAR
2025-03-184/ADreyer Scott — EVP & Chief Commercial OfficerSale (S): 15,387 @ $30.00EDGAR
2025-03-134Dreyer Scott — EVP & Chief Commercial OfficerSale (S): 15,387 @ $30.00EDGAR
2025-03-134Tupper Colleen — EVP & Chief Financial OfficerSale (S): 10,445 @ $30.01EDGAR
2025-03-104Tupper Colleen — EVP & Chief Financial OfficerSale (S): 1,949 @ $30 · Sale (S): 1,504 @ $30.00EDGAR
2025-03-104Dreyer Scott — EVP & Chief Commercial OfficerSale (S): 3,295 @ $30.00 · Sale (S): 2,348 @ $30.00EDGAR
2025-03-064Kuhlmann Shirley R. — EVP and General CounselOption exercise (M): 40,000 @ $24.03 · Sale (S): 40,000 @ $28.08 · Sale (S): 20,000 @ $28.03 · Sale (S): 26,067 @ $28.50 · Option exercise (M): 40,000 (derivative) @ $0EDGAR

Recent 8-K events — COLLEGIUM PHARMACEUTICAL, INC

FiledFormItems reportedSource
2026-08-138-K8.01 — Other EventsEDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
EDGAR
2026-06-308-K/A9.01 — Financial Statements and ExhibitsEDGAR
2026-05-158-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-128-K2.01 — Completion of Acquisition or Disposition of Assets
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-198-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-268-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-088-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=COLL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →